BSN CAPITAL PARTNERS Ltd purchased a new position in The Procter & Gamble Company (NYSE:PG – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 50,000 shares of the company’s stock, valued at approximately $8,331,000. Procter & Gamble makes up 1.6% of BSN CAPITAL PARTNERS Ltd’s investment portfolio, making the stock its 28th largest holding.
Other hedge funds have also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. acquired a new position in Procter & Gamble in the second quarter worth about $28,000. Fairway Wealth LLC acquired a new position in Procter & Gamble in the second quarter worth about $29,000. Transcendent Capital Group LLC bought a new stake in Procter & Gamble during the fourth quarter worth about $31,000. Ruedi Wealth Management Inc. grew its stake in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after buying an additional 77 shares during the last quarter. Finally, POM Investment Strategies LLC bought a new stake in Procter & Gamble during the second quarter worth about $34,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Insider Activity at Procter & Gamble
In related news, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the transaction, the insider now owns 19,341 shares of the company’s stock, valued at approximately $3,319,882.65. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Balaji Purushothaman sold 8,842 shares of Procter & Gamble stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the transaction, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Susan Street Whaley sold 634 shares of Procter & Gamble stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the transaction, the insider now directly owns 19,341 shares of the company’s stock, valued at approximately $3,319,882.65. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 383,194 shares of company stock valued at $65,140,718. Corporate insiders own 0.17% of the company’s stock.
Analysts Set New Price Targets
View Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Trading Up 0.7 %
PG opened at $169.27 on Thursday. The Procter & Gamble Company has a twelve month low of $141.66 and a twelve month high of $177.94. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. The firm’s fifty day moving average is $171.39 and its two-hundred day moving average is $166.65. The firm has a market cap of $399.50 billion, a PE ratio of 27.66, a price-to-earnings-growth ratio of 3.73 and a beta of 0.41.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. During the same period last year, the business posted $1.37 earnings per share. The firm’s quarterly revenue was down .1% on a year-over-year basis. Equities research analysts anticipate that The Procter & Gamble Company will post 6.97 EPS for the current year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.38%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.69%.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- How to Invest in the FAANG Stocks
- Why Netflix Is Irresistible Even At All-Time HighsÂ
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Top 3 Stocks with Explosive Call Option Activity: What to Watch
- 3 Grocery Stocks That Are Proving They Are Still Essential
- The Future of Medical Devices: Two Strong Buys You Can’t Miss
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.